Back to results
US 2019/0290640 A1Published application
Methods Of Providing Weight Loss Therapy In Patients With Major Depression
AssigneeNalpropion Pharmaceuticals LLC
InventorEduardo Dunayevich
Life of this patent
Estimating the term…
Abstract
Disclosed are methods of providing weight loss therapy, particularly for patients suffering from major depression.
Claims20
A method for providing weight loss therapy to a patient, comprising:
- identifying a patient suffering from major depressive disorder, wherein the patient is also overweight or obese;
- and
- reducing weight of the patient by administering to the patient naltrexone or a pharmaceutically acceptable salt thereof and bupropion or a pharmaceutically acceptable salt thereof, wherein the naltrexone or pharmaceutically acceptable salt thereof is in an amount effective to enhance the weight loss activity of the bupropion or pharmaceutically acceptable salt thereof.
A method for providing weight loss therapy to a patient, comprising:
- identifying a patient suffering from major depressive disorder, wherein the patient is also overweight or obese;
- and
- reducing weight of the patient by administering to the patient naltrexone or a pharmaceutically acceptable salt thereof and bupropion or a pharmaceutically acceptable salt thereof, wherein the amount of the naltrexone or pharmaceutically acceptable salt thereof is about 32 mg per day;
- wherein the amount of the bupropion or pharmaceutically acceptable salt thereof is about 360 mg per day;
- and wherein each of the naltrexone or pharmaceutically acceptable salt thereof and bupropion or pharmaceutically acceptable salt thereof is in a sustained release formulation.
2 more elements
Dependencies are inferred from the claim text.